skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Jared Wolff, Jack Allen, and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

 

 

Topics covered in this episode include:

  • Overview of data from Novartis's JULIET trial: CAR-T impact (KITE & JUNO) (0:45
  • Betrixiban's June 24th PDUFA (Portola) in prophylaxis of VTE (8:00)
  • Effect of Xtandi (Pfizer/Astellas) PROSPER trial amendments on prostate cancer market dynamic (Zytiga -JNJ mentioned) (15:12)
  • Scott Gottlieb's agenda as FDA commissioner: Five major policy points and the opioid epidemic (19:40)

 

 

Click here to listen 

 

 

To learn more about Datamonitor Healthcare and our offerings, visit: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare

 

Read also

  • Scrip: industry news and insights, Datamonitor Healthcare: d...

    Top 10 Best-Selling Drugs of 2019

    By Stephanie Yip

    In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

    Topics Drug Review Diseases

  • HBW Insight: Health, Beauty and Wellness, Generics Bulletin,...

    Pharma Intelligence Launches Alexa Skill

    Keep up with topics you care about in Pharma and Medtech with the new Alexa Skill from Informa Pharma Intelligence. Access daily news briefings to stay up to date with the latest news, right from your Alexa smartphone app!

    Topics $name $name $name

  • Scrip: industry news and insights, Datamonitor Healthcare: d...

    Top 10 Best-Selling Drugs of 2019

    By Stephanie Yip

    In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

    Topics Drug Review Diseases

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: